COMPANY
History
- 2020's
- 2010's
- 2000's
2020's
- 2025
- 08
NINOVA Brand Launch
- 09
Implementation of Sales Division Middle Management Training (ASP)
- 10
Launch of New NINOVA Products (Serum, Cream)
- 10
Participation in K-Beauty Expo Vietnam & Saigon
- 11
Participation in K-Beauty Expo Malaysia
- 2024
- 02
INSOL–Healing Sound Business Partnership
- 04
MYHIXEL Launch
- 04
INSOL–Exosystems Strategic Business Partnership
- 2023
- 01
Inauguration of the New CEO
- 05
New Product Launch – INSOL COVID-19 Ag
- 05
New Product Launch – RE:FIT Patch U8
- 06
Participation in the Korean Heart Rhythm Society Annual International Scientific Meeting
- 09
Participation in Pharmedi Vietnam 2023
- 10
Participation in the Korea–Indonesia Medical Roadshow
- 11
INSOL – Solmitech Investment Agreement Ceremony
- 12
INSOL – MYHIXEL Partnership Agreement Ceremony
- 2022
- 03
New Product Launch – Viral Transport Medium (VTM)
- 03
New Product Launch – Saliva DNA Collector
- 03
New Product Launch – Influenza A/B Kit
- 09
Participation in the Korea–Indonesia Future New Industry Business Plaza 2022
- 2021
- 03
Publication of the INSOL Newsletter “Soli News” and Launch of Internal Broadcasting
- 04
Official ISO 13485:2016 Certification
- 04
Completion and Operation of the INSOL Logistics Center
- 05
Headquarters Relocated to Hanam City
- 06
Launch of Wartfreezer
- 07
Operation of the Metaverse Utilization Task Force (TFT)
- 2020
- 05
Selected as the Lead Organization for the Ministry of Trade, Industry and Energy (MOTIE) International Cooperation Project – Eurostars-2
- 05
Selected as the Lead Organization for the Ministry of Trade, Industry and Energy (MOTIE) Core Bio Industry Project
- 09
teswtCertification of GMP for In Vitro Diagnostic Medical Devices
2010's
- 2019
- 06
Selected as a Seoul Work-Life Balance Strong Small Enterprise
- 07
Certified as a Management Innovation Business (Main-Biz) Small and Medium Enterprise
- 07
Attendance at the International AIDS Conference, Mexico
- 08
Certification of Compliance with Medical Device Manufacturing and Quality Management Standards (Certificate of GMP)
- 11
Selected as a Participating Organization for the Ministry of Health and Welfare’s Infectious Disease Crisis Response Technology Development Project
- 12
Selected as an Excellent Job Creation Company by SBA
- 2018
- 03
13th General Shareholders’ Meeting
- 07
Attendance at the International AIDS Conference, Netherlands
- 09
Establishment of a Medical Device Manufacturing Facility and Obtained Manufacturing License
- 10
Relocation of the R&D Research Institute to Misa House D L-Tower
- 12
Completion of the GMP Manufacturing Plant
- 12
Selected as a 2019 “Youth-Friendly Strong Small Enterprise” by the Ministry of Employment and Labor (BEST in Wages / BEST in Work-Life Balance / BEST in Employment Stability)
- 12
Selected as a Military Service Special Exemption Company
- 12
Conducted the Briquette Sharing Charity Campaign
- 2017
- 06
Overseas Incentive Trip: Italy/Greece (June 3–9)
- 09
Support for the Well-Drilling Project in Zambia, Africa
- 11
Kimchi-Making Charity Volunteer Event
- 12
Business Cooperation Agreement Signed with the Korea Basic Science Institute (KBSI)
- 12
Selected as a “Talent Development SME” by the Ministry of SMEs and Startups (2018–2020)
- 12
Selected as a 2018 “Youth-Friendly Strong Small Enterprise” by the Ministry of Employment and Labor (BEST in Wages / BEST in Employment Stability)
- 2016
- 03
Recipient of the 2016 JoongAng Ilbo Customer Love Brand Award
- 05
Overseas Incentive Trip: United States (May 14–20)
- 09
MOU Signed with YiHuo Bio
- 11
Kimchi-Making Charity Volunteer Event
- 12
Agreement Signed to Participate in the Good Neighbors Ethical Consumption Campaign
- 12
Certification of the Affiliated R&D Research Institute
- 12
Opening of the INSOL R&D Center and Certification of the Affiliated Research Institute
- 2015
- 03
10th Anniversary of Foundation
- 04
Launch of INSOL Mall (insolmall.co.kr) and the OraQuick Brand Website (oraquick.co.kr)
- 05
Launch of OraQuick Self-Test HIV/HCV
- 05
Overseas Incentive Trip: Italy (May 21–26)
- 11
Kimchi-Making Charity Volunteer Event
- 11
QED A-150 Certified as New Medical Technology No. 554 by the Ministry of Health and Welfare
- 2014
- 02
Exclusive Supply Agreement Signed with DNA Genotek, Canada
- 08
MOU Signed with Genoplan
- 09
Supply Agreement Signed with Genoplan
- 2013
- 07
Development of the OraQuick Auto Transmission System (Seoul Asan Medical Center)
- 2012
- 07
Sales Partnership with Hyundai Pharm
- 09
INSOL OraQuick HCV Announced with an Approved Non-Reimbursable Code by the Ministry of Health and Welfare
- 2011
- 03
Conducted a Multicenter Clinical Trial for OQ HCV
- 07
Establishment of a Dedicated R&D Research Team
- 09
Extension of the Shelf Life of OQ HIV to 30 Months
- 10
HCV Antibody Test Certified as New Medical Technology No. 175 by the Ministry of Health and Welfare
- 2010
- 08
Completion of the Research Service Project for the Korea Centers for Disease Control and Prevention
- 11
Military Supply of the Cryosurgical Device “Histofreezer”
2000's
- 2008
- 05
OraQuick HIV Rapid Test Certified as No. 1 New Medical Technology by the Ministry of Health and Welfare
- 07
Recognized as a Medical Procedure and Classified as Non-Reimbursable (Health Insurance Review and Assessment Service)
- 07
eSTIM Trademark Publication by the Korean Intellectual Property Office
- 2007
- 02
Import Approval Obtained for the OraQuick Advance Rapid HIV-1/2 Antibody Test
- 03
Import Approval Obtained for the Cryosurgical Device “Histofreezer”
- 03
Obtained License for Medical Device Importation
- 03
Obtained Business Registration for Health Functional Food Importation
- 04
Launch of the Cryosurgical Device “Histofreezer”
- 05
Launch of the OraQuick Advance Rapid HIV-1/2 Antibody Test
- 10
Launch of the Early STD Screening Program “ESTIM” (www.estim.co.kr )
- 11
Patent Filing for the eSTIM Business Model
- 2006
- 02
Supply Agreement Signed with OraSure Technologies, Inc. for In Vitro Diagnostic Products and the Cryosurgical Device “Histofreezer”
- 02
Approval of Korea Good Supply Practice (KGSP) for Pharmaceutical Distribution
- 03
Launch of GIL Thiotepa Injection
- 09
Obtained Import Approval for the OraQuick Advance Rapid HIV-1/2 Antibody Blood Test
- 09
Company Name Changed from Global In-Licensing Korea Co., Ltd. to INSOL Co., Ltd.
- 10
Supply Agreement Signed with CD Pharma (a Subsidiary of VSL Pharmaceuticals) for the VSL#3 Probiotic Product
- 11
Product Name Changed from GIL Thiotepa Injection to INSOL Thiotepa Injection
- 2005
- 04
Partnership Established with C.H.A Japan
- 10
Supply Agreement Signed for Anticancer Drugs with Bedford Laboratories Inc., USA
- 10
Obtained Import Approval for Thiotepa from Bedford Laboratories Inc., USA
- 2004
- 07
Establishment of Global In-Licensing USA
- 12
Establishment of Global In-Licensing Korea Co., Ltd.
